Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × bosutinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Myeloid, Chronic-Phase 4 Philadelphia Chromosome 3 Leukemia 3 Breast Neoplasms 3 Bronchiolitis Obliterans Syndrome 2 Translocation, Genetic 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Glioblastoma 1 Bone Marrow Diseases 1 Blast Crisis 1 Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡